Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Arginine-enriched diet limits plasma and muscle glutamine depletion in head-injured rats.

Moinard C, Belabed L, Gupta S, Besson V, Marchand-Verrecchia C, Chaumeil JC, Cynober L, Charrueau C.

Nutrition. 2006 Oct;22(10):1039-44. Epub 2006 Aug 2.

PMID:
16889936
2.

Autoradiographic analysis of mouse brain kinin B1 and B2 receptors after closed head trauma and ability of Anatibant mesylate to cross the blood-brain barrier.

Ongali B, Hellal F, Rodi D, Plotkine M, Marchand-Verrecchia C, Pruneau D, Couture R.

J Neurotrauma. 2006 May;23(5):696-707.

PMID:
16689671
3.

Impairment of lymphocyte function in head-injured rats: effects of standard and immune-enhancing diets for enteral nutrition.

Belabed L, Charrueau C, Besson V, Gupta S, Walrand S, Marchand-Verrecchia C, Richon S, Nafziger J, Plotkine M, Chaumeil JC, Cynober L, Moinard C.

Clin Nutr. 2006 Oct;25(5):832-41. Epub 2006 May 5.

PMID:
16678308
4.

[Anti-inflammatory modulators in traumatic brain injury].

Lescot T, Marchand-Verrecchia C, Puybasset L.

Ann Fr Anesth Reanim. 2006 Jul;25(7):755-60. Epub 2006 May 3. Review. French.

PMID:
16675184
5.

Selective inhibition of inducible nitric oxide synthase reduces neurological deficit but not cerebral edema following traumatic brain injury.

Louin G, Marchand-Verrecchia C, Palmier B, Plotkine M, Jafarian-Tehrani M.

Neuropharmacology. 2006 Feb;50(2):182-90. Epub 2005 Oct 19.

PMID:
16242164
6.

NMDA receptor activation inhibits alpha-secretase and promotes neuronal amyloid-beta production.

Lesné S, Ali C, Gabriel C, Croci N, MacKenzie ET, Glabe CG, Plotkine M, Marchand-Verrecchia C, Vivien D, Buisson A.

J Neurosci. 2005 Oct 12;25(41):9367-77.

7.

Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, exerts neuroprotective effects in traumatic brain injury.

Besson VC, Chen XR, Plotkine M, Marchand-Verrecchia C.

Neurosci Lett. 2005 Nov 4;388(1):7-12.

PMID:
16087294
8.

Beneficial effects of PJ34 and INO-1001, two novel water-soluble poly(ADP-ribose) polymerase inhibitors, on the consequences of traumatic brain injury in rat.

Besson VC, Zsengellér Z, Plotkine M, Szabó C, Marchand-Verrecchia C.

Brain Res. 2005 Apr 18;1041(2):149-56.

PMID:
15829224
9.

1400W, a potent selective inducible NOS inhibitor, improves histopathological outcome following traumatic brain injury in rats.

Jafarian-Tehrani M, Louin G, Royo NC, Besson VC, Bohme GA, Plotkine M, Marchand-Verrecchia C.

Nitric Oxide. 2005 Mar;12(2):61-9. Epub 2005 Jan 21.

PMID:
15740979
10.

Characterization of the alteration of nutritional state in brain injury induced by fluid percussion in rats.

Moinard C, Neveux N, Royo N, Genthon C, Marchand-Verrecchia C, Plotkine M, Cynober L.

Intensive Care Med. 2005 Feb;31(2):281-8. Epub 2004 Nov 30.

PMID:
15703899
11.

Cortical calcium increase following traumatic brain injury represents a pitfall in the evaluation of Ca2+-independent NOS activity.

Louin G, Besson VC, Royo NC, Bonnefont-Rousselot D, Marchand-Verrecchia C, Plotkine M, Jafarian-Tehrani M.

J Neurosci Methods. 2004 Sep 30;138(1-2):73-9.

PMID:
15325114
12.

Pattern of cerebral edema and hemorrhage in a mice model of diffuse brain injury.

Hellal F, Bonnefont-Rousselot D, Croci N, Palmier B, Plotkine M, Marchand-Verrecchia C.

Neurosci Lett. 2004 Feb 26;357(1):21-4.

PMID:
15036604
13.

Deleterious activation of poly(ADP-ribose)polymerase-1 in brain after in vivo oxidative stress.

Besson VC, Margaill I, Plotkine M, Marchand-Verrecchia C.

Free Radic Res. 2003 Nov;37(11):1201-8.

PMID:
14703732
14.

Detrimental role of bradykinin B2 receptor in a murine model of diffuse brain injury.

Hellal F, Pruneau D, Palmier B, Faye P, Croci N, Plotkine M, Marchand-Verrecchia C.

J Neurotrauma. 2003 Sep;20(9):841-51.

PMID:
14577862
15.

Deleterious poly(ADP-ribose)polymerase-1 pathway activation in traumatic brain injury in rat.

Besson VC, Croci N, Boulu RG, Plotkine M, Marchand-Verrecchia C.

Brain Res. 2003 Oct 31;989(1):58-66.

PMID:
14519512
16.

LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces ischemic brain injury in a murine model of transient focal cerebral ischemia.

Ding-Zhou L, Margaill I, Palmier B, Pruneau D, Plotkine M, Marchand-Verrecchia C.

Br J Pharmacol. 2003 Aug;139(8):1539-47.

18.

L-NAME reduces infarction, neurological deficit and blood-brain barrier disruption following cerebral ischemia in mice.

Ding-Zhou L, Marchand-Verrecchia C, Croci N, Plotkine M, Margaill I.

Eur J Pharmacol. 2002 Dec 20;457(2-3):137-46.

PMID:
12464359

Supplemental Content

Loading ...
Support Center